Published in J Biol Chem on April 25, 1992
Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother (1995) 9.40
Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother (2001) 4.17
Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother (1997) 3.27
Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother (2002) 3.25
Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother (2004) 2.84
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother (1995) 2.58
Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother (1998) 1.76
Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin. BMC Biol (2004) 1.68
Chloroplast ribosomes and protein synthesis. Microbiol Rev (1994) 1.65
Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother (1997) 1.63
Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori. Antimicrob Agents Chemother (2008) 1.08
Mechanism of action of streptogramins and macrolides. Drugs (1996) 1.03
Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics. J Mol Biol (2009) 1.00
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. Antimicrob Agents Chemother (1994) 0.99
The conformation of 23S rRNA nucleotide A2058 determines its recognition by the ErmE methyltransferase. RNA (1995) 0.91
Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain. Nucleic Acids Res (1994) 0.82
Chemobiosynthesis of new antimalarial macrolides. Antimicrob Agents Chemother (2012) 0.77
Genetics of bacterial ribosomes. Annu Rev Genet (1977) 5.64
Characterization of hybrid plasmids carrying individual ribosomal ribonucleic acid transcription units of Escherichia coli. J Bacteriol (1977) 5.37
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res (1984) 3.94
Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli. Methods Enzymol (1988) 3.60
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components. Microbiol Rev (1979) 2.65
Identification of spacer tRNA genes in individual ribosomal RNA transcription units of Escherichia coli. Proc Natl Acad Sci U S A (1977) 2.51
Overlapping functions of the Saccharomyces cerevisiae Mre11, Exo1 and Rad27 nucleases in DNA metabolism. Genetics (2001) 2.46
Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol (1985) 2.31
Some rRNA operons in E. coli have tRNA genes at their distal ends. Cell (1978) 1.91
Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.73
Insertions of Tn 10 into an E. coli ribosomal RNA operon are incompletely polar. Cell (1980) 1.59
Inhibition of protein synthesis by streptogramins and related antibiotics. J Antimicrob Chemother (1997) 1.54
Antitermination mechanisms in rRNA operons of Escherichia coli. J Bacteriol (1986) 1.51
Preparation of a specific RNA probe for detection of Mycobacterium paratuberculosis and diagnosis of Johne's disease. J Clin Microbiol (1993) 1.38
Composition and immunological properties of the protein fraction of A36, a major antigen complex of Mycobacterium paratuberculosis. Scand J Immunol (1992) 1.30
Tn9 and IS1 inserts in a ribosomal ribonucleic acid operon of Escherichia coli are incompletely polar. J Bacteriol (1981) 1.29
Nus A protein affects transcriptional pausing and termination in vitro by binding to different sites on the transcription complex. Biochemistry (1988) 1.29
Antitermination of transcription from an Escherichia coli ribosomal RNA promoter. Proc Natl Acad Sci U S A (1984) 1.18
Isolation and sequencing of the gene coding for an antigenic 34-kilodalton protein of Mycobacterium paratuberculosis. J Bacteriol (1993) 1.18
Cloning and expression of portions of the 34-kilodalton-protein gene of Mycobacterium paratuberculosis: its application to serological analysis of Johne's disease. J Clin Microbiol (1993) 1.17
Efficient read-through of Tn9 and IS1 by RNA polymerase molecules that initiate at rRNA promoters. J Bacteriol (1983) 1.15
Comparative analysis of the genomes of intestinal spirochetes of human and animal origin. Infect Immun (1989) 1.14
Preparation and properties of antigen 60 from Mycobacterium bovis BCG. Clin Exp Immunol (1986) 1.13
Spectinomycin resistance due to a mutation in an rRNA operon of Escherichia coli. J Bacteriol (1983) 1.11
Development of species-specific enzyme-linked immunosorbent assay for diagnosis of Johne's disease in cattle. J Clin Microbiol (1994) 1.11
Metabolism of macromolecules in bacteria treated with virginiamycin. J Gen Microbiol (1969) 1.08
Deletion analysis of the expression of rRNA genes and associated tRNA genes carried by a lambda transducing bacteriophage. J Bacteriol (1979) 1.07
Transcription of Escherichia coli ribosomal DNA in Proteus mirabilis. Mol Gen Genet (1976) 1.06
Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang (2003) 1.06
Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate. Thromb Haemost (1997) 1.05
Unbalanced rRNA gene dosage and its effects on rRNA and ribosomal-protein synthesis. J Bacteriol (1985) 1.05
Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes. J Biol Chem (1987) 1.04
The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes. J Antimicrob Chemother (1989) 1.04
Cross-reactivity of antigens from the cytoplasm and cell walls of some corynebacteria and mycobacteria. J Infect Dis (1985) 1.04
Mechanism of action of streptogramins and macrolides. Drugs (1996) 1.03
Antitermination by both the promoter and the leader regions of an Escherichia coli ribosomal RNA operon. Proc Natl Acad Sci U S A (1985) 1.02
The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases? Curr Pharm Des (2010) 0.97
The role of rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes. J Biol Chem (1992) 0.97
Detection of Mycobacterium avium subsp. paratuberculosis in infected tissues by new species-specific immunohistological procedures. Clin Diagn Lab Immunol (1998) 0.96
A microanalytical procedure for determination of the base composition of DNA. Eur J Biochem (1985) 0.95
Interference of virginiamycin M with the initiation and the elongation of peptide chains in cell-free systems. Biochim Biophys Acta (1974) 0.95
Criteria for operability and reduction of surgical mortality in patients with severe left ventricular ischemia and dysfunction. Ann Thorac Surg (1978) 0.95
Duplex PCR for differential identification of Mycobacterium bovis, M. avium, and M. avium subsp. paratuberculosis in formalin- fixed paraffin-embedded tissues from cattle. J Clin Microbiol (2000) 0.94
Mycobacterial proliferation in macrophages is prevented by incubation with lymphocytes activated in vitro with a mycobacterial antigen complex. Eur J Immunol (1991) 0.94
Induction of cellular immune reactions by A36, an antigen complex of Mycobacterium paratuberculosis: comparison of A36 and johnin components. Scand J Immunol (1992) 0.93
Immunization of mice with the antigen A60 of Mycobacterium bovis BCG. Clin Exp Immunol (1992) 0.92
Chemical composition of antigen 60 from Mycobacterium bovis BCG. Scand J Immunol (1986) 0.90
Definitive evidence for the actual contribution of yeast in the transformation of neutral precursors of grape aromas. J Agric Food Chem (2001) 0.90
Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis. Infect Immun (1993) 0.90
Virginiamycin M, a specific inhibitor of the acceptor site of ribosomes. Biochimie (1971) 0.90
Immunological properties of antigen 60 of BCG. Induction of humoral and cellular immune reactions. Scand J Immunol (1987) 0.89
Immunological relatedness of ribosomes from mycobacteria, nocardiae and corynebacteria, and microorganisms in leprosy lesions. Infect Immun (1978) 0.89
Expression and stability of Escherichia coli F-prime factors in Proteus mirabilis. Mol Gen Genet (1977) 0.89
Formation of chloroplast ribosomes and ribosomal RNA in Euglena incubated with protein inhibitors. Exp Cell Res (1973) 0.88
Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients. Eur J Epidemiol (1985) 0.88
Structure and function of cytoplasmic organelles in transiently and permanently bleached Euglena. Exp Cell Res (1973) 0.87
Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M. Proc Natl Acad Sci U S A (1980) 0.87
Hemodynamic and clinical evaluation of the Hancock xenograft bioprosthesis of aortic valve replacement (with emphasis on management of the small aortic root). J Thorac Cardiovasc Surg (1978) 0.87
Effects of Escherichia coli Nus A protein on transcription termination in vitro are not increased or decreased by DNA sequences sufficient for antitermination in vivo. Biochemistry (1988) 0.86
The properties of virginiamycin-resistant mutants of Bacillus subtilis. J Gen Microbiol (1973) 0.86
A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes. Mol Gen Genet (1978) 0.86
Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis. Clin Diagn Lab Immunol (1994) 0.86
Affinity labeling of the virginiamycin S binding site on bacterial ribosome. Biochemistry (1990) 0.85
Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic. Biochim Biophys Acta (1989) 0.85
Pressure dissociation of bacterial ribosomes and reassociation of ribosomal subunits. Mol Gen Genet (1978) 0.85
Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems. Biochim Biophys Acta (1988) 0.85
Formation and decay of polyribosomes and ribosomes during the inhibition of protein synthesis and recovery. Biochimie (1971) 0.85
Isolation and characterization of a novel glucuronosyl diacylglycerol from Mycobacterium smegmatis. Biochim Biophys Acta (1993) 0.84
Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes. J Biol Chem (1983) 0.84
The lasting ribosome alteration produced by virginiamycin M disappears upon removal of certain ribosomal proteins. Biochim Biophys Acta (1983) 0.84
The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits. Mol Gen Genet (1978) 0.83
Identification of a salvage pathway for D-arabinose in Mycobacterium smegmatis. Eur J Biochem (1988) 0.83
Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems. J Antimicrob Chemother (1985) 0.83
Formation of ribosomal particles in virginiamycin sensitive and resistant mutants of Bacillus subtilis. Biochimie (1973) 0.83
Results of coronary revascularization in patients with recent myocardial infarction. J Thorac Cardiovasc Surg (1978) 0.83
Serological analysis of pulmonary and extrapulmonary tuberculosis with enzyme-linked immunosorbent assays for anti-A60 immunoglobulins. Clin Infect Dis (1994) 0.82
The ribosomal cycle in bacteria treated with an inhibitor of protein synthesis. Biochimie (1973) 0.82
Properties of microorganisms isolated from human leprosy lesions. Rev Infect Dis (1983) 0.82
Saccharomyces cerevisiae cell fatty acid composition and release during fermentation without aeration and in absence of exogenous lipids. Int J Food Microbiol (1999) 0.82
Comparative analysis of three sensitins used in cutaneous testing for tuberculosis and paratuberculosis in cattle. FEMS Microbiol Lett (1993) 0.82
The action of virginiamycin on nucleic acid and protein synthesis in Bacillus subtilis infected with bacteriophage 2C. J Gen Microbiol (1969) 0.82
Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides. Biochim Biophys Acta (1988) 0.82
Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain. Nucleic Acids Res (1994) 0.82
Intrathecal synthesis of anti-mycobacterial antibodies in patients with tuberculous meningitis. An immunoblotting study. J Neurol Neurosurg Psychiatry (1990) 0.82
Origin and metabolic properties of the RNA species formed during the replication cycle of virus 2C. J Virol (1974) 0.82
Modification of factor VIII in therapeutic concentrates after virus inactivation by solvent-detergent and pasteurisation. Thromb Haemost (1998) 0.82
Serological analysis of human tuberculosis by an ELISA with mycobacterial antigen 60. Scand J Infect Dis (1990) 0.81
Structure of the wall polysaccharide isolated from a group of corynebacteria. Eur J Biochem (1982) 0.81
Analysis of fluorescence quenching of ribosome-bound virginiamycin S. J Biol Chem (1984) 0.81